Tech Company Financing Transactions

PMV Pharmaceuticals Funding Round

PMV Pharmaceuticals, based in Cranbury, secured $74 million in investment from Topspin Partners, Euclid Opportunities and InterWest Partners.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series B

Topspin Partners (Lead Investor) (Steve Winick)

Euclid Opportunities

InterWest Partners

OrbiMed (Peter Thompson)

Osage Partners

Proceeds Purpose
The proceeds will be used to develop and advance into the clinic the Company's pipeline of mutant p53 restoration drug candidates.

Company Information

Company Status
Mailing Address
8 Clarke Dr. 3
Cranbury, NJ 08512
Email Address
PMV Pharmaceuticals (Nasdaq: PMVP) is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV combines unique biological understanding with pharmaceutical development focus.
PMV Pharmaceuticals LinkedIn Company Profile
Social Media
PMV Pharmaceuticals Company Twitter Account
Company News
PMV Pharmaceuticals News
PMV Pharmaceuticals on Facebook
PMV Pharmaceuticals on YouTube

Management Team

Email & Social
Chief Executive Officer
David Mack
  David Mack LinkedIn Profile  David Mack Twitter Account  David Mack News  David Mack on Facebook
Chief Medical Officer
Leila Alland
  Leila Alland LinkedIn Profile  Leila Alland Twitter Account  Leila Alland News  Leila Alland on Facebook
Chief Operating Officer
Winston Kung
  Winston Kung LinkedIn Profile  Winston Kung Twitter Account  Winston Kung News  Winston Kung on Facebook
Vice President
Thomas Davis
  Thomas Davis LinkedIn Profile  Thomas Davis Twitter Account  Thomas Davis News  Thomas Davis on Facebook
Vice President
Melissa Dumble
  Melissa Dumble LinkedIn Profile  Melissa Dumble Twitter Account  Melissa Dumble News  Melissa Dumble on Facebook
Vice President
Binh Vu
  Binh Vu LinkedIn Profile  Binh Vu Twitter Account  Binh Vu News  Binh Vu on Facebook
VP - Regulatory Affairs
Deepika Jalota
  Deepika Jalota LinkedIn Profile  Deepika Jalota Twitter Account  Deepika Jalota News  Deepika Jalota on Facebook



Browse more venture capital transactions:

Prev: 2/23/2017: Oncternal Therapeutics venture capital transaction
Next: 2/23/2017: Mailgun venture capital transaction


Share this article


About Database of VC Transactions

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary